Items Tagged ‘ILC’

October 28th, 2015

The Type of Breast Cancer Determines Effectiveness of Different Hormonal Therapies

By

According to the results of a recent study published in the Journal of Clinical Oncology, women with certain subtypes of hormone-positive breast cancer appear to benefit differently when treated with hormone therapy. Hormone-positive breast cancer refers to breast cancer that is stimulated to grow from the female hormone, estrogen. Therefore, a standard treatment component for […]

View full entry

Tags: AI, anti-estrogen agent, aromatase inhibitors, Breast Cancer, Femara, hormone-positive breast cancer, IDC, ILC, letrozole, News, tamoxifen